Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients

被引:3
|
作者
Czibor, Sandor [1 ]
Carr, Robert [2 ]
Redondo, Francisca [3 ]
Auewarakul, Chirayu U. [4 ]
Cerci, Juliano J. [5 ]
Paez, Diana [6 ]
Fanti, Stefano [7 ]
Gyorke, Tamas [1 ]
机构
[1] Semmelweis Univ, Med Imaging Ctr, Dept Nucl Med, Budapest, Hungary
[2] Kings Coll London, Guys & St Thomas Hosp, Dept Hematol, London, England
[3] Fdn Arturo Lopez Perez, Oncol Clin, Santiago, Chile
[4] Chulabhorn Royal Acad, HRH Princess Chulabhorn Coll Med Sci, Fac Med & Publ Hlth, Bangkok, Thailand
[5] PET CT Dept Quanta Diagnost & Terapia, Curitiba, Brazil
[6] IAEA, Dept Nucl Sci & Applicat, Div Human Hlth, Nucl Med & Diagnost Imaging Sect, Vienna, Austria
[7] Univ Bologna, Policlin S Orsola, Metropolitan Nucl Med, Bologna, Italy
关键词
diffuse large B-cell lymphoma; Deauville score; PET; metabolic tumor volume; ratio PET; METABOLIC TUMOR VOLUME; PROGRESSION-FREE SURVIVAL; HODGKIN-LYMPHOMA; RESPONSE ASSESSMENT; FDG-PET/CT; PREDICTION; CRITERIA; IPI;
D O I
10.1097/MNM.0000000000001664
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective2-[F-18]fluoro-2-deoxy-d-glucose PET/computed tomography ([F-18]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. MethodsWe investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (Delta SUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. ResultsA total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different.Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, Delta SUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that Delta SUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). ConclusionBaseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative 'Deauville-like' parameters performing best in the present study.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 50 条
  • [21] Evaluation of the prognostic value of tumor fragmentation on [18F]-FDG PET/CT on an independent cohort of diffuse large B-cell lymphoma patients
    Rebaud, Louis
    Capobianco, Nicolo
    Sibille, Ludovic
    Girum, Kibrom
    Meignan, Michel
    Cottereau, Anne-Segolene
    Vercellino, Laetitia
    Casasnovas, Olivier
    Thieblemont, Catherine
    Spottiswoode, Bruce
    Buvat, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [22] Can metabolic parameters of 18F FDG PET predict cell of origin classification of Diffuse Large B-cell lymphoma (DLBCL) ?
    Choudhury, S.
    Rangarajan, V.
    Agrawal, A.
    Ghosh, S.
    Purandare, N.
    Shah, S.
    Puranik, A.
    Goda, J. Sastri
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S575 - S576
  • [23] Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline 18F-FDG PET-CT
    Delaby, Gauthier
    Hubaut, Marc-Antoine
    Morschhauser, Franck
    Besson, Alix
    Huglo, Damien
    Herbaux, Charles
    Baillet, Clio
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1584 - 1591
  • [24] Prognostic value of 18F-FDG PET and Ki67 in patients with diffuse large B-Cell lymphoma
    Hua, F.
    Guan, Y.
    Zhao, J.
    Feng, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S212 - S212
  • [25] Utility assessment of interim FDG-PET/CT in frontline therapy of patients with diffuse large B-cell lymphoma (DLBCL).
    Huntington, Scott F.
    Nasta, Sunita
    Schuster, Stephen J.
    Doshi, Jalpa
    Svoboda, Jakub
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Prognostic Value of Interim 18F-FDG PET/CT in Patients with Diffuse Large B-Cell Lymphoma: SUVmax Reduction versus Visual Analysis
    Sarandeses Fernandez, P.
    Ruiz Solis, S.
    Hernandez Martinez, A.
    Alvarez, J.
    Gomez Grande, A.
    Estenoz Alfaro, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S643 - S643
  • [27] Application value of 18F-FDG PET/CT metabolic parameters in the prognostic prediction of Diffuse Large B-cell Lymphoma
    Li, J.
    Sun, X.
    Li, Y.
    Yang, J.
    Zhao, Q.
    Yang, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S558 - S558
  • [28] Functional Parameters of 18F-FDG PET/CT in Patients with Primary Testicular Diffuse Large B-Cell Lymphoma
    Yang, Jing
    Zhu, Sha
    Pang, Fuwen
    Xu, Miao
    Dong, Yiting
    Hao, Jianqi
    Ma, Xuelei
    CONTRAST MEDIA & MOLECULAR IMAGING, 2018,
  • [29] F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma
    Gallicchio, Rosj
    Mansueto, Giovanna
    Simeon, Vittorio
    Nardelli, Anna
    Guariglia, Roberto
    Capacchione, Daniela
    Soscia, Ernesto
    Pedicini, Piernicola
    Gattozzi, Domenico
    Musto, Pellegrino
    Storto, Giovanni
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (05) : 382 - 389
  • [30] F-18 FDG PET/CT quantisation parameters as predictors of outcome in patients with diffuse large B-cell lymphoma
    D'Antuono, F.
    Mansueto, G.
    Giacomobono, S.
    Gallicchio, R.
    Nardelli, A.
    Pellegrino, T.
    Tempone, A.
    Leggiadro, F.
    Gattozzi, D.
    Guariglia, R.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S373 - S373